Study S002342

Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05708859
Acronym: T-PLAQUE
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: RECRUITING
Enrollment: 120
Start: 2024-01-02
Primary completion: 2025-12
Lead sponsor: Matthew J. Budoff
Conditions: Type II Diabetes; Atherosclerosis
Interventions: DRUG:Tirzepatide; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

Reduction of total non-calcified coronary plaque volume [12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.